Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Dosoretz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
International Journal of Radiation Oncology, Biology, Physics|April 26, 2011
Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostateKaren M Winkfield, Ming-Hui Chen, Daniel E Dosoretz, et al.
Clinical Genitourinary Cancer|May 25, 2015
Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality RiskLior Z Braunstein, Ming-Hui Chen, Daniel E Dosoretz, et al.
Future Oncology (London, England)|December 20, 2014
The promise of combining radiation therapy and immunotherapy: morbidity and toxicityAndre M Agassi, Francisco A Myslicki, Jesse M Shulman, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 11, 2013
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancerNeal D Shore, Constantine A Mantz, Daniel E Dosoretz, et al.
Brachytherapy|March 30, 2010
The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statementArthur K Cheung, Ming-Hui Chen, Brian J Moran, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2011
Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancerJosephine Kang, Ming-Hui Chen, Yuanye Zhang, et al.
The Journal of Urology|October 25, 2011
Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapyTimur Mitin, Ming-Hui Chen, Yuanye Zhang, et al.
Cancer|January 7, 2010
Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapyAmy M Dosoretz, Ming-Hui Chen, Sharon A Salenius, et al.
The Journal of Urology|May 17, 2011
Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk diseaseNils D Arvold, Ming-Hui Chen, Judd W Moul, et al.
BJU International|March 17, 2010
Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or strokeJulia H Hayes, Ming-Hui Chen, Brian J Moran, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Journal of Radiation Oncology, Biology, Physics|April 26, 2011
Race and survival following brachytherapy-based treatment for men with localized or locally advanced adenocarcinoma of the prostateKaren M Winkfield, Ming-Hui Chen, Daniel E Dosoretz, et al.
Clinical Genitourinary Cancer|May 25, 2015
Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality RiskLior Z Braunstein, Ming-Hui Chen, Daniel E Dosoretz, et al.
Future Oncology (London, England)|December 20, 2014
The promise of combining radiation therapy and immunotherapy: morbidity and toxicityAndre M Agassi, Francisco A Myslicki, Jesse M Shulman, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 11, 2013
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancerNeal D Shore, Constantine A Mantz, Daniel E Dosoretz, et al.
Brachytherapy|March 30, 2010
The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statementArthur K Cheung, Ming-Hui Chen, Brian J Moran, et al.
International Journal of Radiation Oncology, Biology, Physics|September 28, 2011
Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancerJosephine Kang, Ming-Hui Chen, Yuanye Zhang, et al.
The Journal of Urology|October 25, 2011
Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapyTimur Mitin, Ming-Hui Chen, Yuanye Zhang, et al.
Cancer|January 7, 2010
Mortality in men with localized prostate cancer treated with brachytherapy with or without neoadjuvant hormone therapyAmy M Dosoretz, Ming-Hui Chen, Sharon A Salenius, et al.
The Journal of Urology|May 17, 2011
Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk diseaseNils D Arvold, Ming-Hui Chen, Judd W Moul, et al.
BJU International|March 17, 2010
Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or strokeJulia H Hayes, Ming-Hui Chen, Brian J Moran, et al.
Pageof 2